Jpmorgan Chase & CO Pfizer Inc Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Pfizer Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 28,263,342 shares of PFE stock, worth $709 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

28,263,342

Previous 28,263,342 -0.0%

Holding current value

$709 Million

Previous $720 Million -0.0%

% of portfolio

0.05%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$23.29 - $25.88 $93.2 Million - $104 Million	-4,001,316 Reduced 12.4%	28,263,342 $720 Million
Q1 2025 May 12, 2025	BUY	$25.01 - $27.13 $129 Million - $140 Million	5,144,007 Added 18.97%	32,264,658 $818 Million
Q4 2024 Feb 12, 2025	SELL	$24.8 - $30.19 $261 Million - $317 Million	-10,508,722 Reduced 27.93%	27,120,651 $720 Million
Q3 2024 Dec 26, 2024	SELL	$27.7 - $31.39 $28.7 Million - $32.5 Million	-1,035,674 Reduced 2.68%	37,629,373 $1.09 Billion
Q3 2024 Nov 08, 2024	SELL	$27.7 - $31.39 $5.08 Million - $5.76 Million	-183,561 Reduced 0.49%	36,975,535 $1.07 Billion

Q2 2024 Dec 26, 2024	BUY	$25.26 - $29.6 $42.7 Million - $50 Million	1,689,512 Added 4.57%	38,665,047 $1.08 Billion
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $115 Million - $135 Million	-4,561,247 Reduced 10.93%	37,159,096 $1.04 Billion
Q1 2024 Dec 26, 2024	BUY	$25.89 - $29.73 $123 Million - $141 Million	4,744,808 Added 12.83%	41,720,343 $1.16 Billion
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $18.2 Million - $20.9 Million	-703,291 Reduced 1.66%	41,720,343 $1.16 Billion
Q4 2023 Dec 26, 2024	BUY	$26.13 - $33.94 $168 Million - $218 Million	6,419,821 Added 17.36%	43,395,356 $1.25 Billion
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $25.1 Million - $32.6 Million	959,351 Added 2.31%	42,423,634 $1.22 Billion
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $48.5 Million - $56.7 Million	-1,512,254 Reduced 3.52%	41,464,283 $1.38 Billion
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $262 Million - $303 Million	7,246,745 Added 20.28%	42,976,537 $1.58 Billion
Q1 2023 May 18, 2023	BUY	$39.39 - $51.28 $104 Million - $135 Million	2,641,886 Added 7.98%	35,729,792 $1.46 Billion
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $631 Million - $822 Million	-16,022,368 Reduced 32.63%	33,087,906 $1.35 Billion
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $402 Million - $525 Million	9,631,188 Added 24.4%	49,110,274 $2.52 Billion
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $68 Million - $83 Million	-1,552,889 Reduced 3.78%	39,479,086 $1.73 Billion
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $371 Million - $440 Million	7,981,650 Added 24.15%	41,031,975 $2.15 Billion
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $132 Million - $164 Million	2,890,178 Added 9.58%	33,050,325 $1.71 Billion
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $262 Million - $389 Million	6,344,714 Added 26.64%	30,160,147 $1.78 Billion
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $935 Million - $1.2 Billion	23,815,433 New	23,815,433 $1.02 Billion

Others Institutions Holding PFE

# of Institutions

3,355

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Pfizer Inc Transaction History